Home Cart Sign in  
Chemical Structure| 89464-63-1 Chemical Structure| 89464-63-1

Structure of DMOG
CAS No.: 89464-63-1

Chemical Structure| 89464-63-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

DMOG is a HIF-1α stabilizer that inhibits the degradation of HIF-1α. DMOG is primarily used in research on hypoxic responses, angiogenesis, and cancer.

Synonyms: Dimethyloxallyl Glycine; Dimethyloxalylglycine; Dimethyloxaloylglycine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of DMOG

CAS No. :89464-63-1
Formula : C6H9NO5
M.W : 175.14
SMILES Code : O=C(OC)CNC(C(OC)=O)=O
Synonyms :
Dimethyloxallyl Glycine; Dimethyloxalylglycine; Dimethyloxaloylglycine
MDL No. :MFCD05865098
InChI Key :BNJOZDZCRHCODO-UHFFFAOYSA-N
Pubchem ID :560326

Safety of DMOG

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H319-H372-H410
Precautionary Statements:P260-P264-P273-P301+P312-P305+P351+P338-P314
Class:9
UN#:3077
Packing Group:

Related Pathways of DMOG

epigenetics

Isoform Comparison

Biological Activity

Target
  • PHD1

  • Hydroxylase

In Vitro:

Cell Line
Concentration Treated Time Description References
JJ012 cells 0.5 mM 48 h Stabilize HIF1α protein and prevent its degradation, results showed elevated protein levels of HIF1α and total PYGL PMC10592452
HT1080 cells 1 mM 24 h Stabilize HIF1α protein and prevent its degradation, results showed HIF1α interacts with mutant IDH1 in the nuclear fraction PMC10592452
NCM460 human colonocytes 1.0 μg/ml 12 or 24 h To study TcdA-induced VEGF-A production, results showed that TcdA dose-dependently induced VEGF-A production in NCM460 colonocytes PMC6559218
HT29 human colonic cancer cells 1.0 μg/ml 12 or 24 h To study TcdA-induced VEGF-A production, results showed that TcdA induced VEGF-A production in HT29 cells PMC6559218

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Trypanosoma brucei H3.VKO cell line Media supplementation 1mM 5 days DMOG treatment resulted in the complete loss of base J but no termination defects were found PMC4721609
Mice Antibiotic-associated CDI model Intraperitoneal injection 400 mg/kg Starting on the day of C. difficile gavage, lasting for 2 days To study the effect of DMOG on CDI mice, results showed that DMOG significantly exacerbated the death rate in CDI mice PMC6559218
Mice Wild-type mice Intraperitoneal injection 40 mg/kg Once daily for 3 days DMOG-treated mice exhibited cold intolerance with attenuated thermogenic gene expression and beige adipocyte formation in iWAT upon cold exposure PMC9174489
Mice Wild-type mice Intraperitoneal injection 40 mg/kg Daily for 3 days DMOG-administered WT mice were cold intolerant with attenuated thermogenic gene expression and beige adipocyte formation in iWAT upon cold. PMC9174489
Mice Pulmonary fibrosis model Intraperitoneal injection 50 mg/kg 2, 5, 8, 11 days DMOG reversed the inhibitory effect of AsA on HIF-1α, increasing tumor volume, mediastinal lymph node weight, metastatic lung nodule count, and hydroxyproline levels. PMC10680219

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.71mL

1.14mL

0.57mL

28.55mL

5.71mL

2.85mL

57.10mL

11.42mL

5.71mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories